Upregulation of Cav3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain

Pain

Volumn 150, Issue 1, 2010, Pages 183-191

  Takahashi, Tomoko ^a   Aoki, Yuka ^a   Okubo, Kazumasa ^a   Maeda, Yumi ^a   Sekiguchi, Fumiko ^a   Mitani, Kenji ^a   Nishikawa, Hiroyuki ^a   Kawabata, Atsufumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Hydrogen sulfide; Hyperalgesia; Neuropathic pain; Pain; RNA interference; T type calcium channel

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL T TYPE; CYANOALANINE; CYSTATHIONINE GAMMA LYASE; ENZYME INHIBITOR; HYDROGEN SULFIDE; MIBEFRADIL; PROPARGYLGLYCINE; SMALL INTERFERING RNA; SODIUM DITHIONITE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; GENE SILENCING; HYPERALGESIA; INTRAPLANTAR DRUG ADMINISTRATION; LUMBAR SPINE; MAINTENANCE THERAPY; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TARGETING; RAT; RNA INTERFERENCE; SPINAL GANGLION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; HYDROGEN SULFIDE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MIBEFRADIL; NEURALGIA; NEURONS, AFFERENT; PAIN THRESHOLD; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SPINAL NERVES; UP-REGULATION;

EID: 77953023713     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.04.022     Document Type: Article

References (45)

1. Ali M.Y., Ping C.Y., Mok Y.Y., Ling L., Whiteman M., Bhatia M., and Moore P.K. Regulation of vascular nitric oxide in vitro and in vivo: a new role for endogenous hydrogen sulphide?. Br J Pharmacol 149 (2006) 625-634
2. Bhatia M., Zhi L., Zhang H., Ng S.W., and Moore P.K. Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am J Physiol Lung Cell Mol Physiol 291 (2006) L896-L904
3. v 3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24 (2005) 315-324
4. V 3.2 T-type channels. Genes Brain Behav 6 (2007) 425-431
5. Chung J.M., Kim H.K., and Chung K. Segmental spinal nerve ligation model of neuropathic pain. Methods Mol Med 99 (2004) 35-45
6. Cunha T.M., Dal-Secco D., Verri Jr. W.A., Guerrero A.T., Souza G.R., Vieira S.M., Lotufo C.M., Neto A.F., Ferreira S.H., and Cunha F.Q. Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. Eur J Pharmacol 590 (2008) 127-135
7. ATP channels. J Pharmacol Exp Ther 316 (2006) 325-335
8. Dogrul A., Gardell L.R., Ossipov M.H., Tulunay F.C., Lai J., and Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105 (2003) 159-168
9. Flatters S.J., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
10. Gribkoff V.K. The role of voltage-gated calcium channels in pain and nociception. Semin Cell Dev Biol 17 (2006) 555-564
11. Hildebrand M.E., and Snutch T.P. Contributions of T-type calcium channels to the pathophysiology of pain signaling. Drug Discov Today Dis Mech 3 (2006) 335-341
12. Jagodic M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksovic P.M., Rosenberg E.R., Bayliss D.A., Jevtovic-Todorovic V., and Todorovic S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27 (2007) 3305-3316
13. Jagodic M.M., Pathirathna S., Joksovic P.M., Lee W., Nelson M.T., Naik A.K., Su P., Jevtovic-Todorovic V., and Todorovic S.M. Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol 99 (2008) 3151-3156
14. Ji G., Zhou S., and Carlton S.M. Intact Adelta-fibers up-regulate transient receptor potential A1 and contribute to cold hypersensitivity in neuropathic rats. Neuroscience 154 (2008) 1054-1066
15. 2+ channels in the rat and mouse thalamus. J Physiol 574 (2006) 415-430
16. Katsura H., Obata K., Mizushima T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Tokunaga A., Sakagami M., and Noguchi K. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp Neurol 200 (2006) 112-123
17. + channels. Neuropharmacology 51 (2006) 182-190
18. Kawabata A., Ishiki T., Nagasawa K., Yoshida S., Maeda Y., Takahashi T., Sekiguchi F., Wada T., Ichida S., and Nishikawa H. Hydrogen sulfide as a novel nociceptive messenger. Pain 132 (2007) 74-81
19. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
20. Kubo S., Kajiwara M., and Kawabata A. Dual modulation of the tension of isolated gastric artery and gastric mucosal circulation by hydrogen sulfide in rats. Inflammopharmacology 15 (2007) 288-292
21. Kubo S., Kurokawa Y., Doe I., Masuko T., Sekiguchi F., and Kawabata A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 241 (2007) 92-97
22. Lee A.T., Shah J.J., Li L., Cheng Y., Moore P.K., and Khanna S. A nociceptive-intensity-dependent role for hydrogen sulphide in the formalin model of persistent inflammatory pain. Neuroscience 152 (2008) 89-96
23. Li L., and Moore P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?. Trends Pharmacol Sci 29 (2008) 84-90
24. v 3.2 T-type calcium channels. Pain 142 (2009) 127-132
25. Matsunami M., Tarui T., Mitani K., Nagasawa K., Fukushima O., Okubo K., Yoshida S., Takemura M., and Kawabata A. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58 (2009) 751-761
26. V 3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145 (2009) 184-195
27. Milligan E.D., Hinde J.L., Mehmert K.K., Maier S.F., and Watkins L.R. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods 90 (1999) 81-86
28. Morita K., Motoyama N., Kitayama T., Morioka N., Kifune K., and Dohi T. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. J Pharmacol Exp Ther 326 (2008) 633-645
29. 2+ channels. J Neurochem 108 (2009) 676-684
30. Nelson M.T., Woo J., Kang H.W., Vitko I., Barrett P.Q., Perez-Reyes E., Lee J.H., Shin H.S., and Todorovic S.M. Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci 27 (2007) 8250-8260
31. Nishimura S., Fukushima O., Ishikura H., Takahashi T., Matsunami M., Tsujiuchi T., Sekiguchi F., Naruse M., Kamanaka Y., and Kawabata A. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 58 (2009) 762-770
32. 2 S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br J Pharmacol 142 (2004) 31-34
33. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83 (2003) 117-161
34. Picton R., Eggo M.C., Merrill G.A., Langman M.J., and Singh S. Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut 50 (2002) 201-205
35. Ramasamy S., Singh S., Taniere P., Langman M.J., and Eggo M.C. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 291 (2006) G288-G296
36. Schicho R., Krueger D., Zeller F., Von Weyhern C.W., Frieling T., Kimura H., Ishii I., De Giorgio R., Campi B., and Schemann M. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology 131 (2006) 1542-1552
37. Streng T., Axelsson H.E., Hedlund P., Andersson D.A., Jordt S.E., Bevan S., Andersson K.E., Hogestatt E.D., and Zygmunt P.M. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53 (2008) 391-399
38. Sun B, Wang X, Li Q, Dong L, Grundy D, Rong W. Hydrogen sulfide activates gut sensory nerves. Fudan Univ Med Sci 2009;36:52.
39. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6 (2007) 917-935
40. Talley E.M., Cribbs L.L., Lee J.H., Daud A., Perez-Reyes E., and Bayliss D.A. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19 (1999) 1895-1911
41. Taniguchi E., Matsunami M., Kimura T., Yonezawa D., Ishiki T., Sekiguchi F., Nishikawa H., Maeda Y., Ishikura H., and Kawabata A. Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?. Toxicology 264 (2009) 96-103
42. Todorovic S.M., and Jevtovic-Todorovic V. Regulation of T-type calcium channels in the peripheral pain pathway. Channels (Austin) 1 (2007) 238-245
43. Trevisani M., Patacchini R., Nicoletti P., Gatti R., Gazzieri D., Lissi N., Zagli G., Creminon C., Geppetti P., and Harrison S. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 145 (2005) 1123-1131
44. Welker H.A., Wiltshire H., and Bullingham R. Clinical pharmacokinetics of mibefradil. Clin Pharmacokinet 35 (1998) 405-423
45. 2 S in rat insulin-secreting cells and the underlying mechanisms. J Physiol 569 (2005) 519-531